Families USA Issues Statement on Drug Pricing Proposal
* * *
Today,
"Today's announcement--less than two weeks from the elections--could just be an attempt to win over voters and may never come to fruition. I hope this is a serious policy that will be formally proposed and finalized by the Trump administration. If so, it is an important step forward for our nation's seniors and taxpayers.
"The data is clear. The way we currently pay providers and pharmaceutical companies for drugs administered in doctors' offices and hospitals creates perverse financial incentives for these providers to select extraordinarily expensive drugs that may not be the best for their patients. Even more important, the current payment policies also result in patients sometimes getting hurt or dying. Medicare Part B is the perfect example of misaligned incentives, and this proposed rule, if implemented, could pilot significant new ways to pay for drugs that align incentives so that patients get the highest value care, they have the best outcomes possible, and costs come down.
"We hope this move to leverage the power of the federal government to reduce prescription drug prices is more than just election year posturing, and that it reflects a broader shift to using federal negotiating power to get unsustainable prescription drug prices under control for everyone.
"There is no confusion about this. It is the pharmaceutical industry and their astronomical profits, not other countries, which are responsible for high drug prices in
"While the administration is outlining a significant step in the right direction, it is outrageous that


Rep. Kuster Issues Statement on Plan to Overhaul Medicare Drug Prices
Advisor News
- Poor money habits are a dealbreaker in a new relationship
- DC plan sponsors see opportunity in alternatives
- The American Dream: Redefined as financial stability
- Partial annuitization: How advisors can help clients balance income, growth
- Guide women along the walk through widowhood
More Advisor NewsAnnuity News
- Globe Life Inc. (NYSE: GL) Records 52-Week High Thursday Morning
- AM Best Managing Director Joins ‘Target Topics’ Podcast to Discuss State of Delegated Underwriting Authority Enterprises Market
- KBRA Assigns Rating to TruSpire Retirement Insurance Company
- Partial annuitization: How advisors can help clients balance income, growth
- Guide women along the walk through widowhood
More Annuity NewsHealth/Employee Benefits News
- Fewer members, more profit: UnitedHealth shares surge on Q2 earnings beat
- ARE SURVIVAL RATES FOR ADULTS WITH CONGENITAL HEART DISEASE LINKED TO SPECIALIZED CARDIAC CARE ACCESS?
- THIRTY-TWO YEARS, ZERO RESULTS: NRSC CHARGES SHERROD BROWN SOLD OUT TO BIG INSURANCE
- Employers weigh retention, costs in developing benefits strategies
- As beer strike continues, community stands behind workers
More Health/Employee Benefits NewsLife Insurance News
- Globe Life Inc. (NYSE: GL) Records 52-Week High Thursday Morning
- AM Best Upgrades Credit Ratings of Sagicor Financial Company Ltd. and Most of Its Subsidiaries
- Trust, technology and the future of claims
- New York Life Launches an Indemnity Benefit for its Asset Flex Long-Term Care Insurance Solution
- AM Best Affirms Credit Ratings of DB Insurance Co., Ltd.
More Life Insurance News